DC-SIGN: The Strange Case of Dr. Jekyll and Mr. Hyde.
暂无分享,去创建一个
[1] James A. Hutchinson,et al. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance. , 2015, Immunity.
[2] T. D. de Gruijl,et al. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[3] W. Weis,et al. Structural Basis for Selective Recognition of Oligosaccharides by DC-SIGN and DC-SIGNR , 2001, Science.
[4] C. Figdor,et al. Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.
[5] T. Nomura,et al. Regulatory T Cells and Immune Tolerance , 2008, Cell.
[6] J. D. de Fijter,et al. Increased influx of myeloid dendritic cells during acute rejection is associated with interstitial fibrosis and tubular atrophy and predicts poor outcome. , 2012, Kidney international.
[7] J. Garcia-Vallejo,et al. The physiological role of DC-SIGN: a tale of mice and men. , 2013, Trends in immunology.
[8] C. Figdor,et al. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. , 2005, Blood.
[9] K. Mills,et al. Dendritic cells and other innate determinants of T helper cell polarisation. , 2013, Trends in immunology.
[10] R. Steinman,et al. Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas , 2010, Cell.